Clearmind Medicine Inc. (CMND)

Clearmind Medicine Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Cash & Equivalents	3.92	6.57	5.43	0.13	3.71
Short-Term Investments	1.66	0.29	0.09	0.19	-
Cash & Short-Term Investments	5.59	6.86	5.51	0.32	3.71
Cash Growth	-18.62%	24.47%	1609.58%	-91.31%	1396.58%
Other Receivables	0.32	0.18	0.24	0.1	0.13
Receivables	0.32	0.18	0.24	0.1	0.13
Prepaid Expenses	0.04	0.04	0.04	0.01	0.13
Total Current Assets	5.95	7.09	5.79	0.43	3.97
Property, Plant & Equipment	0.02	0.05	0	0.05	0.02
Other Intangible Assets	0.1	0.11	0.12	0.13	0.16
Long-Term Deferred Charges	-	-	-	0.2	-
Other Long-Term Assets	0.02	0.01	0.04	0.01	0.02
Total Assets	6.08	7.26	5.95	0.83	4.16
Accounts Payable	0.68	0.53	0.62	1.4	0.28
Accrued Expenses	0.06	0.05	0.04	0.21	0.01
Current Portion of Long-Term Debt	1.76	-	-	-	-
Current Portion of Leases	0.02	0.04	-	0.04	-
Other Current Liabilities	2.37	3.52	4.31	0.29	-
Total Current Liabilities	4.89	4.13	4.97	1.93	0.29
Long-Term Leases	-	0.02	-	-	-
Total Liabilities	4.89	4.15	4.97	1.93	0.29
Common Stock	26.4	24.17	17.13	6.71	6.38
Retained Earnings	-27.88	-24.02	-18.77	-10.15	-3.58
Comprehensive Income & Other	2.67	2.96	2.62	2.33	1.08
Shareholders' Equity	1.19	3.11	0.98	-1.11	3.87
Total Liabilities & Equity	6.08	7.26	5.95	0.83	4.16
Total Debt	1.78	0.05	-	0.04	-
Net Cash (Debt)	3.81	6.81	5.51	0.28	3.71
Net Cash Growth	-44.10%	23.51%	1840.56%	-92.34%	1396.58%
Net Cash Per Share	29.95	87.87	-	-	-
Filing Date Shares Outstanding	0.16	0.11	0.08	-	-
Total Common Shares Outstanding	0.16	0.11	0.02	-	-
Working Capital	1.06	2.96	0.82	-1.5	3.68
Book Value Per Share	7.54	29.14	64.77	-	-
Tangible Book Value	1.1	3	0.86	-1.24	3.71
Tangible Book Value Per Share	6.93	28.13	56.92	-	-
Machinery	-	-	-	-	0.02

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q